Delta opioid receptor agonist reduces anxiety-like behavior in mice

Anxiety-related disorders can have a profound impact on the mental health and quality of life of affected individuals.

Evolving overdose crisis shakes previously effective treatments

“You can’t inject a horse tranquilizer and think nothing bad is gonna happen” to you, said Ty Sears, 33, a longtime drug user now in

November 21, 2023

QL-401 by QLSF Biotherapeutics for Refractory Acute Myeloid Leukemia: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

January 6, 2025

Study Challenges Schizophrenia Guidelines

Switching to clozapine after a first schizophrenia relapse was associated with a lower risk of second relapse compared with other strategies, a population-based cohort study

January 30, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.